The combination of strong revenue growth, raised guidance, and leadership continuity suggests continued momentum. Traders should monitor the execution of the 2026 guidance and integration of the new CFO.
Price Chart
Executive Summary
CareDx reported strong 2025 financial results with 14% year-over-year revenue growth to $380 million and raised 2026 guidance to $420-$444 million, while also announcing a CFO transition with Nathan Smith's resignation and Keith Kennedy's appointment. The company maintained solid cash flow and executed significant share repurchases.
Key Financial Metrics
Key Facts
- Full year 2025 revenue was $380 million, up 14% YoY
- 2026 revenue guidance raised to $420-$444 million
- CFO Nathan Smith resigned, Keith Kennedy appointed as new CFO
- Non-GAAP net income grew to $32 million in 2025 from $31 million in 2024
- Cash flow from operations was $42 million in 2025
- Company repurchased $88 million of shares in 2025
Financial Impact
Revenue growth of 14% in 2025 and raised guidance for 2026 indicate strong business momentum
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Testing services | $275.0M | +10.0% |
| Patient and digital solutions | $57.0M | +31.0% |
| Product | $48.0M | +19.0% |
Risk Factors
- CFO transition could create short-term uncertainty
- Medicare LCD impact of $7.5 million estimated in 2026 guidance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K/A Filing (Primary) | 0001217234-26-000019 |
| Document: cdna-20260224.htm | 0001217234-26-000019 |
| Document: 0001217234-26-000019-index-headers.html | 0001217234-26-000019 |
| Document: 0001217234-26-000019-index.html | 0001217234-26-000019 |
| Document: 0001217234-26-000019.txt | 0001217234-26-000019 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Insider Cluster | $44.81 $47.38 | ▲ +5.74% | ▲ +4.52% | $67.15 (+49.85%) |
Aug 4, 2026 8w ago | 144 | $45.50 $47.31 | ▲ +3.98% | ▲ +3.63% | $67.15 (+47.58%) |
Jul 17, 2026 11w ago | Insider Cluster | $39.73 $37.61 | ▼ −5.34% | ▼ −4.65% | $67.15 (+69.02%) |
Jun 16, 2026 15w ago | Insider Cluster | $23.48 $27.13 | ▲ +15.55% | ▲ +16.59% | $67.15 (+185.99%) |
Jun 5, 2026 17w ago | DEFA14A | $21.95 $24.08 | ▲ +9.70% | ▲ +7.59% | $67.15 (+205.92%) |
Apr 28, 2026 22w ago | S-3ASR | $20.80 $20.70 | ▼ −0.48% | ▼ −3.59% | $67.15 (+222.84%) |
Apr 16, 2026 24w ago | 8-K | $22.42 $20.06 | ▼ −10.53% | ▼ −11.51% | $67.15 (+199.51%) |
Feb 25, 2026 31w ago | 8-K/A | $18.46 $19.06 | ▲ +3.25% | ▲ +4.35% | $67.15 (+263.76%) |
Feb 24, 2026 31w ago | 8-K | $18.46 $19.06 | ▲ +3.25% | ▲ +4.35% | $67.15 (+263.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access